Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Galmed Pharmaceuticals Ltd. buy Wells Fargo & Company

Galmed Pharmaceuticals Ltd.
Start price
€6.40
21.02.25 / 50%
Target price
€88.72
21.02.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 21.02.26. The prediction end date can be changed by Wells_Fargo___Compan at any time.
Performance without dividends (%)
Name 1w 1m
Galmed Pharmaceuticals Ltd. - -
iShares Core DAX® 1.043% -0.149%
iShares Nasdaq 100 1.920% 4.604%
iShares Nikkei 225® 4.840% 8.328%
iShares S&P 500 1.567% 3.310%

Comments by Wells_Fargo___Compan for this prediction

In the thread Galmed Pharmaceuticals Ltd. diskutieren
Prediction Buy
Perf. (%) -
Target price 88.722
Change
Ends at 21.02.26

Globus Medical, Inc. (NYSE: GMED) had its price target lowered by analysts at Wells Fargo & Company from $95.00 to $93.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat

Wells Fargo & Company 
0
Report Share
21.02.25

Stopped prediction by Wells_Fargo___Compan for Galmed Pharmaceuticals Ltd.

buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
08.08.25
€56.60
08.08.26
-
19.09.24

Wells Fargo & Company 
08.08.25 50%
buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
11.12.24
€90.54
11.12.25
-
19.09.24

Wells Fargo & Company 
11.12.24 50%
buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
06.11.24
€81.94
06.11.25
-
19.09.24

Wells Fargo & Company 
06.11.24 50%